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ABSTRACT
Background: Spirocerca lupi is a nematode that causes nodules in the esophagus and aortic aneurysms in dogs. Animals 
are infected by eating intermediate host (beetle) containing infective larvae or consuming viscera containing parasitic 
cysts from paratenic hosts. Dogs commonly have a subclinical presentation, but the most common signs are vomiting and 
regurgitation. Visualizing nodules or neoplastic masses via esophagoscopy and the presence of S. lupi eggs in feces are 
the best diagnostic methods. Milbemycin oxime is effective as a treatment for S. lupi. The objective of this study was to 
describe the diagnostic and medical management of a patient with dysphagia secondary to esophageal S. lupi nodules.
Case: A 7-year-old male German shepherd dog was referred for endoscopic examination. The animal presented with 
chronic severe dysphagia and weight loss with a presumptive diagnosis of an esophageal foreign body. At palpation of 
the neck, the dog was painful just dorsal to the cricoid cartilage and had submandibular lymphadenomegaly. The animal 
also exhibited a dropped jaw which could be returned to its normal position by manipulation. Radiographic examination 
demonstrated a radiopaque image compatible with a mass in the cranial esophagus just caudal to the upper esophageal 
sphincter. A fluoroscopy study was performed and confirmed the presence of a mass apparently within the esophageal 
wall preventing the passage of food. Additionally, in this case, small amounts of contrast medium were visualized passing 
into the dog trachea. The animal was hospitalized exhibiting odynophagia, dysphagia and regurgitation.  Blood analysis 
revealed a hypochromic normocytic anemia, severe thrombocytopenia and hipoalbuminemia. A commercial ELISA test 
for Ehrlichia spp. and Anaplasma spp. was performed (SNAP 4Dx plus, IDEXX®). The test was positive for Ehrlichia 
spp. and doxycycline treatment was started. Fluoroscopy was performed using iodinated contrast, and we observed a soft 
tissue density structure at the ventral wall of the esophagus that was not permitting the passage of the contrast through the 
upper esophageal sphincter. One week after doxycycline treatment the animal showed a improvement, with appetite and 
increased weight. In addition, the dropping jaw was no longer evident, but, the dysphagia continued. Laboratory analyses 
were repeated, and values were  within the normal ranges. Esophagoscopy was performed which allowed us to observe a 
mass suggestive of a nodule secondary to S. lupi. This nodule was found in the cranial esophagus and could not be biop-
sied. However S. lupi eggs were observed in the fecal study. The patient was treated with milbemycin oxime to which the 
patient responded favorably, regaining the ability to swallow and gaining weight.
Discussion: Spirocercosis is a parasitic disease with a worldwide distribution which occurs mainly in warm climates as 
in the present case. Dogs often have a subclinical presentation; however when present, the most common clinical signs 
are regurgitation and vomiting. In the present case the patient had severe chronic dysphagia as the principal sign, which 
makes this case atypical. Dysphagia occurred in this case because a nodule was formed in the cranial esophagus, which 
is also rare. This location made it impossible to take endoscopic biopsies, as described by other authors. However, the 
diagnosis was made by identifying microscopic parasites eggs in the stool test. In addition, dog improved with medical 
treatment with milbemycin oxime, at the present, no longer shows dysphagia, odynophagia or coughs and has improved 
their body condition. This is the first official report of the presence of canine Spirocerca lupi in Ciudad Juarez, Mexico. 
Finally, dysphagia is an uncommon sign in dogs with spirocercosis; however, esophageal nodules secondary to S. lupi 
should be considered as a cause of this sign.
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INTRODUCTION
Spirocercosis is a parasitic disease character-
ized by the presence of nodules in the esophagus, 
aorta and stomach [21]. Generally, causes a subclinical 
presentation, but, fatal lesions may occur due to aortic 
aneurysm or rupture of blood vessels [3]. The most 
common signs are vomiting, regurgitation and emacia-
tion. To a minor degree, dyspnea, dysphagia, saliva-
tion, odynophagia, aspiration pneumonia and weight 
loss can be observed [3,13]. Previously, the nodules 
were referred to as granulomas, but histologically this 
is inappropriate [22]. Animals are infected by inges-
tion of beetles containing Spirocerca lupi larvae or from 
consumption of a variety of paratenic hosts [22]. The 
larvae penetrate the stomach wall and migrate through 
the arteries, and they arrive at the thoracic aorta from 
which they migrate to the esophagus. In the esophagus, 
the parasite reaches its adult stage and produces eggs 
that are eliminated in the feces [3]. Radiographic stud-
ies may be suggestive of S. lupi infection if they dem-
onstrate mass in the esophagus. However, the definitive 
diagnosis is made by the presence of S. lupi eggs in the 
feces [13,24]. Additionally, with esophagoscopy we 
can observe nodules and esophageal damage and ob-
tain biopsies [1,3,13]. Early to mature benign nodules 
are smooth, round and sessile that protrudes into the 
esophageal. Conversely, neoplastic nodules generally 
have a roughened, ulcerated and necrotic surface that 
should be biopsied [3]. Milbemycin oxime, have been 
evaluated as a treatment for S. lupi [8,17]. The aim of 
this study was to describe the diagnostic and medical 
management of a patient with severe dysphagia second-
ary to an S. lupi esophageal nodule.
CASE
A 7-year-old male German shepherd dog with 
history of cough and severe chronic dysphagia was 
referred for esophagoscopy. According to the owner, 
the cough had been present for two months and was 
exacerbated by food intake, and the dog also had spo-
radic painful swallowing and regurgitation. The refer-
ring veterinary clinic was suspicious of an esophageal 
foreign body.
Physical examination showed a body condition 
score of 2/5 (22 kg), according to the scale of Laflamme 
in 1997 [10]. The dog was painful on palpation of the 
cranial neck region just dorsal to the cricoid cartilage 
and had right submandibular lymphadenomegaly. 
The dog also exhibited a dropped jaw which could be 
returned to its normal position by manipulation.
Plain radiographs of the cervical esophagus 
and thorax were taken. Gas in the cranial esophagus 
and the presence of a radiopaque structure with soft 
tissue density dorsal to the cricoid cartilage were 
observed on the lateral cervical radiograph (Figure 
1). On the thoracic radiographs only a bronchial pat-
tern was found.
The patient was hospitalized and administered 
meloxicam (Mobicox®)1 at 0.2 mg/kg IM SID for 
analgesia and ranitidine (Ranulin®)2 at 2 mg/kg SC 
BID for its prokinetic action and protective effects on 
the gastric mucosa. The patient was also started on 
intravenous fluid therapy with Hartmann’s solution 
(Solucion HT PISA®)2 at the maintenance dose. Dur-
ing hospitalization the dog exhibited odynophagia, 
dysphagia and regurgitation.
Blood cell analysis revealed a hypochromic 
normocytic anemia and severe thrombocytopenia (55 x 
109/L, reference value 160-465 x 109/L). Blood chem-
istry showed a urea concentration of 13.67 mmol/L 
(3.5-6.0 mmol/L), creatinine of 144 mmol/L (20-110 
mmol/L) and hypoalbuminemia at 21.24 g/L (26-35 
g/L). The urinalysis demonstrated hyperesthenuria. 
Because anemia and thrombocytopenia were found, a 
commercial ELISA test for Ehrlichia and Anaplasma 
was performed (SNAP 4Dx plus, IDEXX®)3. The 
test was positive for Ehrlichia, doxycycline (Vibram-
icina®)4 treatment was started (10 mg/kg PO SID for 
30 days) and the endoscopic procedure was postponed. 
However, fluoroscopy was performed using iodinated 
contrast administered within food, and we observed a 
soft tissue density structure at the ventral wall of the 
esophagus that was not permitting the passage of the 
contrast through the upper esophageal sphincter. In 
addition, the contrast fluid was observed leaking into 
the trachea (Figure 2).
The dog was fed in the high position as used 
in patients with megaesophagus. No regurgitation 
was observed and its appetite was increased in this 
position, but the dysphagia continued. At this point, 
the presumptive diagnosis for the dog was canine 
polymyositis secondary to ehrlichiosis as reported by 
Evans et al. [6]. This possibly explained the dropping 
jaw and the dysphagia due to inflammatory myositis of 
the masticatory muscles affecting muscles innervated 
by the mandibular branch of the trigeminal nerve, 
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including the masseter, temporalis, pterygoids, tensor 
tympani, and tensor veli palatini muscles [6]. 
Seven days after doxycycline treatment the dog 
showed a slight improvement, with a better appetite 
and increased weight. On physical examination, the 
dropping jaw was no longer apparent. However, the 
dysphagia continued. Preoperative laboratory analyses 
were repeated, and all values were  within the normal 
ranges. Therefore, the animal underwent endoscopy. 
Tracheoscopy and bronchoscopy were performed first. 
The walls of the trachea and bronchi were hyperemic 
with hemorrhagic areas and abundant mucus. Bronchial 
washing and brushing was performed for cytological 
examination (Figure 3).
Next, esophagoscopy was performed, and a 
mass with smooth, regular borders was observed in 
the ventral wall of the esophagus. Because of the 
hard consistency of the mass, it was impossible to 
obtain a biopsy sample, but a cytology specimen was 
obtained via brushing. The endoscopic image was 
suggestive of an S. lupi nodule, therefore, a fecal 
analysis was indicated.
A severe suppurative inflammatory reaction 
was reported on the cytologic analysis of the tracheo-
bronchial washing and brushing studies. No significant 
changes were found from the esophageal brushing 
samples. Fecal analysis revealed embryonated, thick-
shelled, small parasitic ova of S. lupi. Hence the case 
was diagnosed as spirocercosis.
Treatment with milbemycin oxime (Intercep-
tor®)5 was started at a dose of 0.5 mg/kg PO SID admin-
istered on days 0, 7, and 27, followed by administration 
once a month for six months.
The dog went home on treatment for ehrlichiosis 
and spirocercosis, and a feeding regime similar to that 
for megaesophagus with metabolic energy requirements 
diet for weight gain.
One month after initiating treatment, the dog no 
longer exhibited regurgitation. The dog was fed similar 
to a megaesophagus patient without restriction, 4-5 times 
a day with a homemade diet. At physical examination 
the patient was normal and had gained weight.
Three months after treatment with milbemycin 
oxime the dog showed significant improvement, had no 
further dysphagia, regurgitation, or cough and reached 
26 kg in body weight. Six months after starting treatment 
the patient was eating a commercial dry food in the nor-
mal position and continued to be free of clinical signs.
Figure 1. Lateral conventional radiograph of the cervical esophagus 
shows a radiopaque structure with soft tissue density dorsal to the 
cricoid cartilage and air in the cranial esophagus.
Figure 2. Esophageal fluoroscopy with iodinated contrast 
administered within food.  The image shows a soft tissue density 
structure at the ventral wall of the esophagus. Additionally, contrast 
fluid was observed into the trachea.
Figure 3. Tracheoscopy showed a hyperemic trachea with 
hemorrhagic areas and abundant mucus.
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DISCUSSION
The German shepherd dog has been reported 
to be a high risk for Spirocerca lupi infection [20,22]. 
The animal in this case presented some characteristic 
signs of spirocercosis such as regurgitation, vomiting, 
weight loss, coughing and hypochromic microcytic 
anemia [3,13,17]; however, the dog presented chronic 
dysphagia as the principal sign, which is not commonly 
reported for this disease.
Dysphagia in dogs is classified based on the 
location of the abnormality and this can be divided 
into oropharyngeal, esophageal and gastroesophageal 
[18]. Esophageal masses may result in dysphagia, and 
in particular, those involving the thoracic esophagus 
can be identified radiographically. Spirocerca lupi 
nodules can result in radiographically apparent esopha-
geal masses. However most nodules produced by this 
nematode are present in the thoracic esophagus near 
the lower esophageal sphincter [3]. Due to this com-
mon location, dysphagia is not reported as a common 
sign in dogs with S. lupi [5,23], and in cases where it 
does happen, dysphagia would be classified such gas-
troesophageal type. In contrast, the cranial esophageal 
nodule that presented in this dog caused an esophageal 
dysphagia. Nodules resulting from S. lupi can protrude 
into the esophageal lumen in cases of early to mature 
nodules. Usually there are one to four nodules in the 
caudal esophagus submucosa ranging from <1 to >4 cm 
in diameter that contain between three and six worms 
[2]. The nodules vary and not only bulge into the lumen 
of the esophagus but also distort the esophageal wall 
and extend into the surrounding mediastinal tissues 
[22]. Esophagoscopy is reported to be the most sensi-
tive method for spirocercosis diagnosis [19]. Benign 
nodules are usually described as small and smooth with 
a nipple-like protuberance. In contrast, neoplastic nod-
ules generally are roughened, ulcerated and present a 
necrotic surface that should be biopsied [3]. However, in 
a report of two cases of spirocercosis the nodules were 
described as smooth, which was an unexpected finding 
in malignant nodules [5]. Even though endoscopy is a 
reliable tool, unclear cases need to be monitored care-
fully for their response to treatment.
In the present case the nodule was relatively 
large (approximately 4 cm) and had a smooth appear-
ance with a small opening. However, the nodule had 
a hard consistency which prevented us from obtaining 
a biopsy with 2.3 mm endoscopic forceps. We think a 
factor for failing to obtain the sample was the cranial 
location of the nodule, because it was mentioned that 
the distal portion of the esophagus, just at the gastro-
esophageal junction, is the most feasible zone to obtain 
endoscopic biopsies. However, even in this distal area, 
biopsies are not always obtained or are of diagnostic 
quality, because only 40% of biopsies from healthy dogs 
are of diagnostic quality [15,16]. The strength of the 
stratified squamous epithelium over intact esophageal 
mucosa supports the resistance to damage created by 
endoscopic biopsy forceps. Successive biopsies at the 
same site for deep tissue of the lamina propria are rec-
ommended to maximize diagnostic information [18,22].
 In this case, a tracheal brush sample demon-
strated a severe suppurative inflammatory reaction sec-
ondary to aspiration pneumonia [7] which could explain 
the chronic cough. However, it is also possible that the 
growth of the nodule in the wall of the esophagus may 
have pressed on the trachea causing coughing.
The mandibular paralysis in this animal was 
initially attributed to a polymyositis secondary to Eh-
rlichia canis which can affect the muscles innervated 
by the mandibular branch of the trigeminal nerve [6]. 
However, one week after treatment with doxycycline 
the patient’s jaw dropping improved but the dysphagia 
continued. It was therefore likely that the dysphagia 
was not secondary to polymyositis and the dropped jaw 
could have been due to canine trigeminal neuropathy 
which improves without treatment after an average of 
22 days [14].
Moreover, although the normochromic normo-
cytic anemia was reported as due to spirocercosis, in our 
case it could also have been secondary to ehrlichiosis 
because after treatment with doxycycline the blood 
analysis was normal [11].
Some drugs have been used for the treatment 
of spirocercosis in dogs [12]. For example, doramectin 
has been effective; however, administration is inconve-
nient as it has be to injected [17]. Milbemycin oxime 
administered orally is a relatively inexpensive and 
efficacious drug against S. lupi in dogs. The treatment 
was successful in animals with nodules and is effective 
in resolving clinical signs. In this case, esophagoscopy 
studies must be repeated to evaluate the evolution of 
the nodule and the effectiveness of treatment, which 
according to case reports, may take 3-5 months to clear 
the spirocercosis nodule [8,9,17].
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The present case is the first official report of 
the presence of canine spirocercosis in Ciudad Juarez, 
Mexico. It describes a German shepherd dog with an 
esophageal nodule secondary to S. lupi whose main 
sign was chronic dysphagia. Although dysphagia is 
reported as a sign of spirocercosis in dogs, rarely is it 
the most important sign as in this case. The dysphagia 
in this dog was attributed to the nodule location in the 
Figure 4. Fecal analysis showed embryonated, thick-shelled, small 
parasitic ova of Spirocerca lupi.
cranial esophagus, which is also rare. Endoscopy is an 
effective diagnostic modality, even if biopsies are not 
obtained. If suggestive nodules are noted in the esopha-
gus, serial fecal analyses are required for a definitive 
diagnosis. The patient presented in this case improved 
with medical treatment with milbemycin oxime; the 
dog no longer shows dysphagia or odynophagia, has 
stopped coughing, has an improved body condition and 
is more active. In dogs, even though prevalence is low, 
Spirocerca lupi nodules should therefore be considered 
as a cause of dysphagia.
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